IXC 0.00% 7.1¢ invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-139

  1. 9,902 Posts.
    lightbulb Created with Sketch. 224
    Yes, agree tax loss is still happening, but opportunity cost of holding, considering the likely lengthy timeframe to potential re-rate, would surely discount the cash per share value now - unless they do send everyone a cheque, but it is highly unlikely they will close the doors and distribute cash IMO.

    Cheers

    Cabe

 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
0.000(0.00%)
Mkt cap ! $5.335M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 532 7.3¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8695 1
View Market Depth
Last trade - 16.12pm 09/08/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.